ResearcherAffiliated Hospital of Qingdao UniversityActive in the last 2 years
Xinting Pan
Matched on ORCID iD 0000-0003-2450-2710; OpenAlex author ID A5079757050.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 2, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- [Retracted] PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo. First author DOI 10.3892/ijmm.2024.5459↗
- Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo. Co-author DOI 10.1371/journal.pone.0185507↗
- PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo. First author DOI 10.3892/ijmm.2015.2096↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Qingyun Zhu · 3 shared papers, 2015–2025
- Paper [Retracted] PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in… DOI 10.3892/ijmm.2024.5459↗
- Paper Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo. DOI 10.1371/journal.pone.0185507↗
- Paper PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo. DOI 10.3892/ijmm.2015.2096↗
- Kun Li · 2 shared papers, 2015–2025
- Paper [Retracted] PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in… DOI 10.3892/ijmm.2024.5459↗
- Paper PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo. DOI 10.3892/ijmm.2015.2096↗
- Liangyu Mi · 1 shared paper, 2017
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.